Decreases in Dietary Preference Produce Increased Emotionality and Risk for Dietary Relapse

Biological Psychiatry

Volumn 61, Issue 9, 2007, Pages 1021-1029

  Teegarden, Sarah L ^a   Bale, Tracy L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anxiety; diet; high fat; obesity; stress; withdrawal

Indexed keywords

CORTICOTROPIN RELEASING FACTOR;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; EMOTIONALITY; FEEDING BEHAVIOR; FOOD PREFERENCE; GENE EXPRESSION; LIPID DIET; MALE; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PRIORITY JOURNAL; REWARD; RISK ASSESSMENT; STRESS; TREATMENT FAILURE;

ANIMALS; ANXIETY; BLOTTING, WESTERN; DIET, REDUCING; DIETARY CARBOHYDRATES; DIETARY FATS; EMOTIONS; FOOD PREFERENCES; GENE EXPRESSION; IN SITU HYBRIDIZATION; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; RECURRENCE; RISK;

EID: 34047263811     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2006.09.032     Document Type: Article

References (46)

1. Bailey A., Davis L., Lesscher H.M., Kelly M.D., Ledent C., Hourani S.M., and Kitchen I. Enhanced morphine withdrawal and micro-opioid receptor G-protein coupling in A2A adenosine receptor knockout mice. J Neurochem 88 (2004) 827-834
2. Bale T.L., Anderson K.R., Roberts A.J., Lee K.F., Nagy T.R., and Vale W.W. Corticotropin-releasing factor receptor-2-deficient mice display abnormal homeostatic responses to challenges of increased dietary fat and cold. Endocrinology 144 (2003) 2580-2587
3. Bale T.L., Contarino A., Smith G.W., Chan R., Gold L.H., Sawchenko P.E., et al. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet 24 (2000) 410-414
4. Blendy J.A., and Maldonado R. Genetic analysis of drug addiction: The role of cAMP response element binding protein. J Mol Med 76 (1998) 104-110
5. Blundell J.E., Lawton C.L., Cotton J.R., and Macdiarmid J.I. Control of human appetite: Implications for the intake of dietary fat. Annu Rev Nutr 16 (1996) 285-319
6. Chaki S., Hirota S., Funakoshi T., Suzuki Y., Suetake S., Okubo T., et al. Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-met hoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor. J Pharmacol Exp Ther 304 (2003) 818-826
7. Colantuoni C., Schwenker J., McCarthy J., Rada P., Ladenheim B., Cadet J.L., et al. Excessive sugar intake alters binding to dopamine and mu-opioid receptors in the brain. Neuroreport 12 (2001) 3549-3552
8. Dallman M.F., Pecoraro N., Akana S.F., La Fleur S.E., Gomez F., Houshyar H., et al. Chronic stress and obesity: A new view of "comfort food". Proc Natl Acad Sci U S A 100 (2003) 11696-11701
9. Davis C., Strachan S., and Berkson M. Sensitivity to reward: Implications for overeating and overweight. Appetite 42 (2004) 131-138
10. De Araujo I.E., and Rolls E.T. Representation in the human brain of food texture and oral fat. J Neurosci 24 (2004) 3086-3093
11. Dudman J.T., Eaton M.E., Rajadhyaksha A., Macías W., Taher M., Barczak A., et al. Dopamine D1 receptors mediate CREB phosphorylation via phosphorylation of the NMDA receptor at Ser897-NR1. J Neurochem 87 (2003) 922-934
12. Fantino M., Hosotte J., and Apfelbaum M. An opioid antagonist, naltrexone, reduces preference for sucrose in humans. Am J Physiol 251 (1986) R91-R96
13. Green S.M., Burley V.J., and Blundell J.E. Effect of fat- and sucrose-containing foods on the size of eating episodes and energy intake in lean males: Potential for causing overconsumption. Eur J Clin Nutr 48 (1994) 547-555
14. Hajnal A., Smith G.P., and Norgren R. Oral sucrose stimulation increases accumbens dopamine in the rat. Am J Physiol Regul Integr Comp Physiol 286 (2004) R31-R37
15. Imaizumi M., Takeda M., and Fushiki T. Effects of oil intake in the conditioned place preference test in mice. Brain Res 870 (2000) 150-156
16. Kelley A.E. Ventral striatal control of appetitive motivation: Role in ingestive behavior and reward-related learning. Neurosci Biobehav Rev 27 (2004) 765-776
17. Koob G.F. Stress, corticotropin-releasing factor, and drug addiction. Ann N Y Acad Sci 897 (1999) 27-45
18. Kreek M.J., and Koob G.F. Drug dependence: Stress and dysregulation of brain reward pathways. Drug Alcohol Depend 51 (1998) 23-47
19. Levine A.S., Kotz C.M., and Gosnell B.A. Sugars: Hedonic aspects, neuroregulation, and energy balance. Am J Clin Nutr 78 (2003) 834S-842S
20. Li J., Li Y.H., and Yuan X.R. Changes of phosphorylation of cAMP response element binding protein in rat nucleus accumbens after chronic ethanol intake: Naloxone reversal. Acta Pharmacol Sin 24 (2003) 930-936
21. Marks-Kaufman R., and Kanarek R.B. Modifications of nutrient selection induced by naloxone in rats. Psychopharmacology (Berl) 74 (1981) 321-324
22. Marks-Kaufman R., and Kanarek R.B. Diet selection following a chronic morphine and naloxone regimen. Pharmacol Biochem Behav 35 (1990) 665-669
23. McClung C.A., and Nestler E.J. Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat Neurosci 6 (2003) 1208-1215
24. Millan M.J., Brocco M., Papp M., Serres F., La Rochelle C.D., Sharp T., et al. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: III. Actions in models of potential antidepressive and anxiolytic activity in comparison with ropinirole. J Pharmacol Exp Ther 309 (2004) 936-950
25. Nestler E.J. Molecular mechanisms of drug addiction. Neuropharmacology 47 suppl 1 (2004) 24-32
26. Nestler E.J., Barrot M., and Self D.W. DeltaFosB: A sustained molecular switch for addiction. Proc Natl Acad Sci U S A 98 (2001) 11042-11046
27. Olausson P., Jentsch J.D., Tronson N., Nestler E.J., and Taylor J.R. dFosB in the nucleus accumbens regulates food-reinforced instrumental behavior and motivation. J Neurosci 26 (2006) 9196-9204
28. Paxinos G., and Franklin K.B.J. The Mouse Brain in Stereotaxic Coordinates. 2nd ed. (2001), Academic Press, San Diego, CA
29. Pecoraro N., Reyes F., Gomez F., Bhargava A., and Dallman M.F. Chronic stress promotes palatable feeding, which reduces signs of stress: Feedforward and feedback effects of chronic stress. Endocrinology 145 (2004) 3754-3762
30. Perrotti L.I., Hadeishi Y., Ulery P.G., Barrot M., Monteggia L., Duman R.S., and Nestler E.J. Induction of deltaFosB in reward-related brain structures after chronic stress. J Neurosci 24 (2004) 10594-10602
31. Plaut S.M., and Friedman S.B. Stress, coping behavior and resistance to disease. Psychother Psychosom 38 (1982) 274-283
32. Pluzarev O., and Pandey S.C. Modulation of CREB expression and phosphorylation in the rat nucleus accumbens during nicotine exposure and withdrawal. J Neurosci Res 77 (2004) 884-891
33. Rodriguez de Fonseca F., Carrera M.R., Navarro M., Koob G.F., and Weiss F. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 276 (1997) 2050-2054
34. Rolls E.T. The functions of the orbitofrontal cortex. Brain Cogn 55 (2004) 11-29
35. Sarnyai Z. Neurobiology of stress and cocaine addiction. Studies on corticotropin-releasing factor in rats, monkeys, and humans. Ann N Y Acad Sci 851 (1998) 371-387
36. Shimazaki T., Iijima M., and Chaki S. Anxiolytic-like activity of MGS0039, a potent group II metabotropic glutamate receptor antagonist, in a marble-burying behavior test. Eur J Pharmacol 501 (2004) 121-125
37. Sinha R., Garcia M., Paliwal P., Kreek M.J., and Rounsaville B.J. Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry 63 (2006) 324-331
38. Smith G.P. Accumbens dopamine mediates the rewarding effect of orosensory stimulation by sucrose. Appetite 43 (2004) 11-13
39. Spooren W.P., Vassout A., Neijt H.C., Kuhn R., Gasparini F., Roux S., et al. Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. J Pharmacol Exp Ther 295 (2000) 1267-1275
40. Stein C.J., and Colditz G.A. The epidemic of obesity. J Clin Endocrinol Metab 89 (2004) 2522-2525
41. Volkow N.D., and Wise R.A. How can drug addiction help us understand obesity?. Nat Neurosci 8 (2005) 555-560
42. Wang G.J., Volkow N.D., Thanos P.K., and Fowler J.S. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: A concept review. J Addict Dis 23 (2004) 39-53
43. Weiss F., Ciccocioppo R., Parsons L.H., Katner S., Liu X., Zorrilla E.P., et al. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann N Y Acad Sci 937 (2001) 1-26
44. Welch C.C., Kim E.M., Grace M.K., Billington C.J., and Levine A.S. Palatability-induced hyperphagia increases hypothalamic Dynorphin peptide and mRNA levels. Brain Res 721 (1996) 126-131
45. Zhang M., Gosnell B.A., and Kelley A.E. Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens. J Pharmacol Exp Ther 285 (1998) 908-914
46. Zhou Y., Spangler R., Ho A., and Kreek M.J. Increased CRH mRNA levels in the rat amygdala during short-term withdrawal from chronic "binge" cocaine. Brain Res Mol Brain Res 114 (2003) 73-79